Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress

Free Radical Biology and Medicine

Volumn 32, Issue 11, 2002, Pages 1050-1060

  Butterfield, D Allan ^a   Lauderback, Christopher M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Amyloid peptide; Free radicals; Lipid peroxidation; Neurotoxicity; Protein oxidation

Indexed keywords

2,4 DINITROPHENYLHYDRAZINE; 3 NITROTYROSINE; 4 HYDROXYNONENAL; ACROLEIN; ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; ARACHIDONIC ACID; BETA ACTIN; CATALASE; CHOLINE ACETYLTRANSFERASE; COPPER ZINC SUPEROXIDE DISMUTASE; CREATINE KINASE BB; DOCOSAHEXAENOIC ACID; FREE RADICAL; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; ISOPROSTANE DERIVATIVE; MANGANESE SUPEROXIDE DISMUTASE; METHIONINE SULFOXIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNINDEXED DRUG;

ALLELE; ALZHEIMER DISEASE; BRAIN REGION; BRAIN SYNAPTOSOME; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; GENOTYPE; HIPPOCAMPUS; HUMAN; LIPID PEROXIDATION; NEUROTOXICITY; NITRATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEOMICS; REVIEW; ANIMAL; METABOLISM; OXIDATION REDUCTION REACTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; FREE RADICALS; HUMANS; LIPID PEROXIDATION; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 0036591849     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)00794-3     Document Type: Article

References (118)

1. Advances in Alzheimer's disease
2. Oxidative stress hypothesis in Alzheimer's disease
3. Amyloid β-protein and the genetics of Alzheimer's disease
4. In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment
5. Nerve growth factor potentiates the neurotoxicity of beta amyloid
6. Beta-amyloid induces neuritic dystrophy in vitro: Similarities with Alzheimer pathology
7. β-Amyloid-associated free radical oxidative stress and neurotoxicity: Implications for Alzheimer's disease
8. Review: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity
9. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42)
10. Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity
11. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins
12. Evidence of oxidative damage in Alzheimer's disease brain: Central role of amyloid beta-peptide
13. Review: Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contributes to neuronal death
14. Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's Aβ(1-42) and Aβ(25-35)
15. Beta-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to Alzheimer's disease
16. Melatonin prevents beta-amyloid-induced lipid peroxidation
17. Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells
18. Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide
19. Characterization of 8-epiprostaglandin F2α as a marker of amyloid β-peptide-induced oxidative damage
20. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide
21. Amyloid beta-peptides increase annular and bulk fluidity and induce lipid peroxidation in brain synaptic plasma membranes
22. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins
23. Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: Relevance to brain lipid peroxidation in neurodegenerative disease
24. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures
25. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro
26. Evidence of an oxidative challenge in the Alzheimer's brain
27. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease
28. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease
29. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease
30. Apolipoprotein E allele-dependent antioxidant activity in brains with Alzheimer's disease
31. Apoliprotein E knock-out synaptosomes are vulnerable to Aβ(1-40)-induced oxidative injury
32. 31P NMR spectroscopy detects altered phospholipids metabolism in Alzheimer's disease
33. Evidence for a membrane defect in Alzheimer disease brain
34. Regional membrane phospholipid alterations in Alzheimer's disease
35. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease
36. Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition
37. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde, and related aldehydes
38. Protein oxidation processes in aging brain
39. 4-Hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease
40. 4-Hydroxynonenal-derived advanced lipid peroxidation products are increased in Alzheimer's disease
41. 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease
42. Human glutathione transferase A4-4 crystal structures and mutagenesis reveal the basis of high catalytic efficiency with toxic lipid peroxidation products
43. Decreased glutathione transferase in brain and ventricular fluid in Alzheimer's disease
44. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal
45. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation
46. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis
47. Determination of the product of lipid peroxidation 4-hydroxy-2-nonenal in clinical samples by gas chromatography-negative ion-chemical ionization mass spectroscopy of the O-pentafluorobenzyl oxime
48. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats
49. NMDA-dependent superoxide production and neurotoxicity
50. Glutamate transporters in neurologic disease
51. Beta-amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: Implications for Alzheimer's disease
52. Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures
53. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes
54. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: The role of Aβ1-42
55. Oxidative modification of glutamine synthetase by amyloid beta peptide
56. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease
57. Oxidatively-induced structural alteration of glutamine synthetase assessed by analysis of spin labeled incorporation kinetics: Relevance to Alzheimer's disease
58. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation
59. Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease
60. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures
61. Formation of isoprostanes-like compounds (neuroprostanes) in vivo from docosahaexanoic acid
62. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo
63. Cerebrospinal fluid F2 isoprostane levels are increased in Alzheimer's disease
64. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients
65. Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease
66. Protein oxidation and aging
67. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-phenylnitrone
68. Biochemistry and pathology of radical-mediated protein oxidation
69. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer disease
70. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders
71. An assessment of oxidative damage to proteins, lipids, and DNA in brains from patients with Alzheimer's disease
72. Protein oxidation in the brain in Alzheimer's disease
73. Oxidative damage in Alzheimer's
74. Direct evidence of oxidative injury by the Alzheimer's amyloid peptide in cultured hippocampal neurons
75. The antioxidant vitamin E modulates amyloid β-peptide-induced creatine kinase inhibition and increased protein oxidation: Implications for the free radical hypothesis of Alzheimer's disease
76. Alzheimer's amyloid-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: Protective effect of vitamin E
77. Vitamin E prevents Alzheimer's amyloid-peptide (1-42)-induced protein oxidation and reactive oxygen species formation
78. Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress
79. Spin labeling in disease
80. Amyloid-peptide-associated free radical oxidative stress, neurotoxicity and Alzheimer's disease
81. Electron paramagnetic resonance investigations of free radical-induced alterations in neocortical synaptosomal membrane protein infrastructure
82. In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain
83. Peroxynitrite-induced alterations in synaptosomal membrane proteins: Insight into oxidative stress in Alzheimer's disease
84. Ischemia/reperfusion induced changes in membrane proteins and lipids of gerbil cortical synaptosomes
85. 5-Aminosalicylic acid protection against oxidative damage to synaptosomal membranes by alkoxyl radicals in vitro
86. Prevention of hyperoxia-induced alterations in synaptosomal membrane-associated proteins by N-tert-butyl-phenylnitrone (PBN) and 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol)
87. The free radical antioxidant vitamin E protects cortical synaptosomal membrane proteins from amyloid -peptide (25-35) toxicity but not from hydroxynonenal toxicity: Relevance to the free radical hypothesis of Alzheimer's disease
88. Oxidative chemistry of peroxynitrite
89. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer's brain indicates region-specific accumulation
90. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease
91. Widespread peroxynitrite-mediated damage in Alzheimer's disease
92. Evidence of neuronal oxidative damage in Alzheimer's disease
93. Inhibition of peroxynitrite dependent tyrosine nitration by hydroxycinnamates: Nitration or electron donation?
94. LC-MS-MS detection of peroxynitrite-derived 3-nitrotyrosine in rat microvessels
95. Oxidative modification of creatine kinase BB in Alzheimer's disease brain
96. The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease
97. Decreased level of creatine kinases BB in the frontal cortex of Alzheimer patients
98. Brain glutathione peroxidase in neurodegenerative disorders
99. Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type
100. Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease
101. Free radicals in the genesis of Alzheimer's disease
102. Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type
103. Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain
104. Apolipoprotein E modulates Aβ1-42-induced oxidative damage to synaptosomes in an allele-specific manner
105. Methionine residues as endogenous antioxidants in proteins
106. Oxidation of methionyl residues in proteins: Tools, targets, and reversal
107. Diastereoselective reduction of protein-bound methionine sulfoxide by methionine sulfoxide reductase
108. Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain
109. Apoptosis in neurodegenerative disorders
110. Oxidative regulation of fatty acid-induced tau polymerization
111. Amyloid beta-peptide impairs ion-motive ATPase activities: Evidence for a role in loss of neuronal Ca2+ homeostasis and cell death
112. Impairment of membrane transport and signal transduction systems by amyloidogenic proteins
113. Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons
114. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
115. Neuroinflammatory signaling upregulation in Alzheimer's disease
116. Fibrillar Alzheimer's amyloid peptide Abeta(1-42) stimulates low density lipoprotein binding and cell association, free radical production and cell cytotoxicity in PC12 cells
117. Oxidative stress in synaptosomal proteins from mutant presenilin-1 knock-in mice: Implications for familial Alzheimer's disease
118. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: Creatine Kinase BB, glutamine synthetase, and ubiquitin C-terminal hydrolase L-1